Edition:
United States

DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

57.34USD
16 Feb 2018
Change (% chg)

$0.63 (+1.11%)
Prev Close
$56.71
Open
$56.79
Day's High
$57.78
Day's Low
$56.37
Volume
229,318
Avg. Vol
457,395
52-wk High
$86.21
52-wk Low
$42.63

Select another date:

Mon, Jan 8 2018

BRIEF-DexCom Says Preliminary Q4 Revenue Was $218 Mln

* DEXCOM REPORTS RECORD PRELIMINARY, UNAUDITED REVENUE FOR THE FOURTH QUARTER AND FISCAL YEAR 2017 AND PROVIDES INITIAL 2018 OUTLOOK

BRIEF-Dexcom announces development agreement with Lilly

* Dexcom announces development agreement with Lilly to integrate Dexcom CGM into connected diabetes ecosystem

BRIEF-Dexcom Inc reports Q3 GAAP loss per share $0.02

* Dexcom, inc. Reports record third quarter 2017 financial results

BRIEF-‍Tandem Diabetes Care to provide all t:slim X2 insulin pump features approved in 2018 to users at no cost

* ‍Tandem Diabetes Care to provide all t:slim x2 insulin pump features approved in 2018 to users at no cost, expands existing dexcom welcome offer for animas customers​

BRIEF-‍Janus Henderson reports 10.2 pct passive stake in Dexcom

* ‍Janus Henderson Group PLC reports a 10.2 percent passive stake in Dexcom Inc as of sept 30 - SEC filing​ Source text: (http://bit.ly/2ybb4kH) Further company coverage:

BRIEF-Fitbit and Dexcom to develop Continuous Glucose Monitoring Experience for people living with diabetes

* ‍Fitbit and DexCom to develop Continuous Glucose Monitoring (CGM) experience for people living with diabetes​

BRIEF-Tandem Diabetes Care announces FDA approval, launch of t:slim X2 insulin pump with Dexcom G5 mobile CGM integration

* Tandem Diabetes care announces FDA approval and launch of t:slim X2 insulin pump with Dexcom G5 mobile CGM integration

BRIEF-DexCom ‍publishes new study on people with type 2 diabetes

* DexCom-‍ published new study showing type 2 diabetes people on a multiple daily injection insulin therapy benefit from use of continuous glucose monitoring​ Source text for Eikon: Further company coverage:

Select another date: